Company Filing History:
1 out of 415 
1 out of 11 
Years Active: 2022
Title: Habib Hajimolahoseini: Innovator in Long QT Syndrome Diagnosis
Introduction
Habib Hajimolahoseini is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of medical diagnostics, particularly in the detection of long QT syndrome. His innovative approach has the potential to improve patient outcomes through early diagnosis and classification.
Latest Patents
Hajimolahoseini holds a patent for a method of diagnosing and classifying long QT syndrome. This method involves obtaining data from an electrocardiogram (ECG) signal, identifying features based on inflection points, and categorizing segments of the ECG signal. The classification determines whether the ECG signal is normal or indicative of long QT syndrome. Additionally, the method can differentiate between Type 1 and Type 2 long QT syndrome. He has 1 patent related to this groundbreaking work.
Career Highlights
Throughout his career, Hajimolahoseini has worked with esteemed institutions such as Queen's University at Kingston and Kingston Health Sciences Centre. His work in these organizations has allowed him to collaborate with other professionals and contribute to advancements in medical technology.
Collaborations
Hajimolahoseini has collaborated with notable colleagues, including Damian P Redfearn and Javad Hashemi. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of medical diagnostics.
Conclusion
Habib Hajimolahoseini's contributions to the diagnosis of long QT syndrome exemplify the impact of innovative thinking in medicine. His work not only advances the field but also holds promise for improving patient care through early detection and classification.